Division of Stroke and Critical Care CUMC NINY
LIMITS: Levels of Inflammatory Markers in the Treatment of Stroke


   

Known risk factors for stroke, including hypertension, diabetes mellitus, smoking and hyperlipidemia, account for only about 50% of stroke risk. The purpose of this study is to gather information about the role of blood tests (such as C-reactive protein) that might help predict the risk of recurrent stroke in people who have already had a first stroke. These blood tests measure levels of inflammation in the body and have been thought to reflect an increased risk of stroke.

Eligible Participants will consist of patients already enrolled into the SPS3 study.

Participation Includes: blood tests

©2004-2006 The Neurological Institute of New York • Affiliated with New York-Presbyterian Hospital
• Columbia University Medical Center • Division of Stroke and Critical Care • 710 W 168th St, New York, NY 10032
Updated September 6, 2006
Comments